Announced Wed, 10 Jun · 19:03 IST
Audio Recording of the Q4 and year ended for the FY26 'Earnings Conference Call'
Investor Communications View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹2325.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.1+0.3+9.7+12.5+12.3+11.0+11.6+17.8——
Up moveDown movePending
AI summary
Fredun Pharmaceuticals has informed BSE that the audio recording of its Q4 and full-year FY26 earnings conference call, held on 10th June 2026, is now available on the company's investor relations website. The call discussed the audited financial results for the quarter and year ended 31st March 2026. Signed by Managing Director Fredun Nariman Medhora, this is a routine SEBI LODR compliance disclosure.
Likely market impact
Investors and analysts can now access the management commentary from the FY26 results call via the company's website to gain additional context beyond the financial numbers already filed.